HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of employing a ¹⁰B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapy.

AbstractOBJECTIVES:
To evaluate the effects of employing a (10)B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapy (BNCT) by measuring the response of intratumour quiescent (Q) cells.
METHODS:
B16-BL6 melanoma tumour-bearing C57BL/6 mice were continuously given 5-bromo-2'-deoxyuridine (BrdU) to label all proliferating (P) cells. The tumours received reactor thermal neutron beam irradiation following the administration of a (10)B-carrier [L-para-boronophenylalanine-(10)B (BPA) or sodium mercaptoundecahydrododecaborate-(10)B (BSH)] in combination with an acute hypoxia-releasing agent (nicotinamide) or mild temperature hyperthermia (MTH). Immediately after the irradiation, cells from some tumours were isolated and incubated with a cytokinesis blocker. The responses of the Q and total (P+Q) cell populations were assessed based on the frequency of micronuclei using immunofluorescence staining for BrdU. In other tumour-bearing mice, macroscopic lung metastases were enumerated 17 days after irradiation.
RESULTS:
BPA-BNCT increased the sensitivity of the total tumour cell population more than BSH-BNCT. However, the sensitivity of Q cells treated with BPA was lower than that of BSH-treated Q cells. With or without a (10)B-carrier, MTH enhanced the sensitivity of the Q cell population. Without irradiation, nicotinamide treatment decreased the number of lung metastases. With irradiation, BPA-BNCT, especially in combination with nicotinamide treatment, showed the potential to reduce the number of metastases more than BSH-BNCT.
CONCLUSION:
BSH-BNCT in combination with MTH improves local tumour control, while BPA-BNCT in combination with nicotinamide may reduce the number of lung metastases.
AuthorsS Masunaga, Y Sakurai, H Tanaka, M Suzuki, Y Liu, N Kondo, A Maruhashi, Y Kinashi, K Ono
JournalThe British journal of radiology (Br J Radiol) Vol. 85 Issue 1011 Pg. 249-58 (Mar 2012) ISSN: 1748-880X [Electronic] England
PMID22391496 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Borohydrides
  • Radiation-Sensitizing Agents
  • Sulfhydryl Compounds
  • Vitamin B Complex
  • mercaptoundecahydrododecaborate
  • Niacinamide
  • Bromodeoxyuridine
Topics
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Borohydrides (pharmacology)
  • Boron Neutron Capture Therapy (methods)
  • Bromodeoxyuridine
  • Cell Hypoxia (drug effects)
  • Female
  • Hyperthermia, Induced (methods)
  • Lung Neoplasms (prevention & control, secondary)
  • Melanoma, Experimental (pathology, radiotherapy)
  • Mice
  • Mice, Inbred C57BL
  • Neoplasm Transplantation
  • Niacinamide (pharmacology)
  • Radiation-Sensitizing Agents (pharmacology)
  • Skin Neoplasms (radiotherapy)
  • Sulfhydryl Compounds (pharmacology)
  • Vitamin B Complex (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: